Graduate School of Public Health, Department of Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Amyotroph Lateral Scler Frontotemporal Degener. 2021 Aug;22(5-6):395-400. doi: 10.1080/21678421.2021.1887262. Epub 2021 Apr 16.
In 2010, the United States Agency for Toxic Substances and Disease Registry (ATSDR) created the National ALS Registry (Registry) to examine the epidemiology of ALS and potential risk factors. We are currently recruiting population-based controls for an epidemiologic case-control study to examine ALS environmental risk factors using this Registry. To date, we have recruited 181 non-diseased, population-based controls for comparison to Registry cases ( = 280). Here we report our recruitment methods for controls and the associated response rates and costs. : Eligible ALS cases had complete risk factor survey data, DNA analysis, and blood concentrations of persistent organic pollutants (POPs). Age, sex, and county-matched controls were identified from commercial/consumer databases using a targeted landline phone sample. Eligible controls were consented, surveyed, and mailed the POPs' blood analysis consent form. Once consented, phlebotomy was scheduled. : We mailed 3760 recruitment letters for 181 potential case-matches across 42 states between 9/2018 and 3/2020. After making phone contact and determining eligibility, 146 controls agreed to participate (response rate = 11.4%, cooperation rate = 22.8%). To date, 127 controls completed the survey and bloodwork. Though controls were matched to cases on age, sex, and county, unmatched characteristics (e.g. smoking) did not differ statistically. Interviewing and incentive costs are estimated at $211.85 per complete participation. : Recruiting matched population-based controls for comparison to cases from the Registry for a study involving completion of a detailed survey and blood specimen provision is relatively feasible and cost effective. This recruitment method could be useful for case-control studies of other rare disorders.
2010 年,美国毒物和疾病登记署(ATSDR)创建了国家肌萎缩侧索硬化症登记处(Registry),以研究肌萎缩侧索硬化症的流行病学和潜在的危险因素。我们目前正在招募基于人群的对照者,以开展一项流行病学病例对照研究,使用该登记处研究肌萎缩侧索硬化症的环境危险因素。迄今为止,我们已经招募了 181 名非患病的基于人群的对照者与登记处病例( = 280)进行比较。在这里,我们报告我们的对照招募方法以及相关的响应率和成本。
合格的肌萎缩侧索硬化症病例具有完整的危险因素调查数据、DNA 分析和持久性有机污染物(POPs)的血液浓度。使用目标固定电话样本,从商业/消费者数据库中确定年龄、性别和县匹配的对照者。合格的对照者同意参加、接受调查并邮寄 POPs 血液分析同意书。一旦同意,就安排采血。
我们在 2018 年 9 月至 2020 年 3 月期间向 42 个州的 181 名潜在病例匹配者邮寄了 3760 份招募信。在进行电话联系并确定资格后,有 146 名对照者同意参加(响应率=11.4%,合作率=22.8%)。迄今为止,已有 127 名对照者完成了调查和血液检查。尽管对照者与病例在年龄、性别和县方面相匹配,但不匹配的特征(如吸烟)在统计学上没有差异。采访和激励费用估计为每个完整参与的人 211.85 美元。
从登记处招募匹配的基于人群的对照者进行病例对照研究,以比较完成详细调查和提供血液样本的情况,相对可行且具有成本效益。这种招募方法可用于其他罕见疾病的病例对照研究。